Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report)’s stock price passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $3.81 and traded as low as $3.59. Arcadia Biosciences shares last traded at $3.6190, with a volume of 5,250 shares.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Arcadia Biosciences in a research report on Monday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.
Get Our Latest Stock Report on Arcadia Biosciences
Arcadia Biosciences Stock Performance
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last released its quarterly earnings data on Friday, November 7th. The basic materials company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.54) by $1.16. The business had revenue of $1.30 million for the quarter, compared to analysts’ expectations of $1.90 million. Arcadia Biosciences had a negative net margin of 97.97% and a negative return on equity of 8.80%.
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Further Reading
- Five stocks we like better than Arcadia Biosciences
- How to Calculate Inflation Rate
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- How to Calculate Stock Profit
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- Investing in Construction Stocks
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
